 Karl Bayer
Concepts (308)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 70 | 2025 | 185 | 20.960 |
Why?
| | Long-Term Potentiation | 24 | 2025 | 199 | 8.430 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 25 | 2025 | 218 | 5.870 |
Why?
| | Hippocampus | 32 | 2025 | 929 | 4.090 |
Why?
| | Long-Term Synaptic Depression | 9 | 2023 | 55 | 3.360 |
Why?
| | Synapses | 17 | 2024 | 426 | 3.170 |
Why?
| | Phosphorylation | 39 | 2025 | 1760 | 2.790 |
Why?
| | Memory | 6 | 2024 | 258 | 2.670 |
Why?
| | Calcium | 21 | 2024 | 1180 | 2.500 |
Why?
| | Neuronal Plasticity | 9 | 2025 | 302 | 1.950 |
Why?
| | Neurons | 23 | 2025 | 1601 | 1.940 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 14 | 2011 | 174 | 1.920 |
Why?
| | Death-Associated Protein Kinases | 3 | 2021 | 10 | 1.880 |
Why?
| | Glutamic Acid | 9 | 2023 | 255 | 1.760 |
Why?
| | Brain Ischemia | 3 | 2025 | 343 | 1.530 |
Why?
| | Calmodulin | 10 | 2019 | 71 | 1.410 |
Why?
| | Neuroprotective Agents | 4 | 2025 | 138 | 1.360 |
Why?
| | Rats | 34 | 2025 | 5594 | 1.260 |
Why?
| | Animals | 64 | 2025 | 37217 | 1.240 |
Why?
| | Heart Arrest | 3 | 2021 | 383 | 1.090 |
Why?
| | Protein Binding | 19 | 2025 | 2225 | 1.090 |
Why?
| | Dendritic Spines | 4 | 2024 | 68 | 1.030 |
Why?
| | Amyloid beta-Peptides | 3 | 2025 | 229 | 1.010 |
Why?
| | Cell Death | 5 | 2021 | 375 | 0.970 |
Why?
| | Ischemia | 3 | 2020 | 414 | 0.930 |
Why?
| | HEK293 Cells | 9 | 2025 | 728 | 0.930 |
Why?
| | Cyclopentanes | 1 | 2025 | 19 | 0.910 |
Why?
| | Receptors, Metabotropic Glutamate | 2 | 2022 | 38 | 0.850 |
Why?
| | Learning | 2 | 2024 | 422 | 0.820 |
Why?
| | Rats, Sprague-Dawley | 17 | 2020 | 2499 | 0.780 |
Why?
| | Amino Acid Sequence | 14 | 2019 | 2155 | 0.760 |
Why?
| | Alzheimer Disease | 3 | 2025 | 564 | 0.720 |
Why?
| | Protein Processing, Post-Translational | 4 | 2019 | 462 | 0.720 |
Why?
| | Mice | 21 | 2024 | 17814 | 0.710 |
Why?
| | Electrophysiological Phenomena | 1 | 2021 | 58 | 0.680 |
Why?
| | CA1 Region, Hippocampal | 1 | 2021 | 52 | 0.670 |
Why?
| | Protein Kinase Inhibitors | 8 | 2018 | 907 | 0.670 |
Why?
| | Alternative Splicing | 5 | 2006 | 227 | 0.660 |
Why?
| | N-Methylaspartate | 9 | 2022 | 43 | 0.640 |
Why?
| | Nitric Oxide | 2 | 2014 | 893 | 0.610 |
Why?
| | Holoenzymes | 2 | 2021 | 25 | 0.610 |
Why?
| | Disks Large Homolog 4 Protein | 1 | 2019 | 19 | 0.610 |
Why?
| | Cerebral Cortex | 3 | 2021 | 452 | 0.600 |
Why?
| | Mutation | 9 | 2020 | 3987 | 0.590 |
Why?
| | Brain | 7 | 2019 | 2792 | 0.590 |
Why?
| | Post-Synaptic Density | 6 | 2016 | 11 | 0.580 |
Why?
| | Peptides | 6 | 2023 | 976 | 0.570 |
Why?
| | Cells, Cultured | 13 | 2021 | 4181 | 0.550 |
Why?
| | Lipoylation | 1 | 2017 | 17 | 0.550 |
Why?
| | Green Fluorescent Proteins | 6 | 2025 | 398 | 0.540 |
Why?
| | Molecular Sequence Data | 12 | 2014 | 2923 | 0.530 |
Why?
| | Adenosine Diphosphate | 3 | 2015 | 82 | 0.530 |
Why?
| | Protein Transport | 8 | 2019 | 444 | 0.530 |
Why?
| | Synaptic Transmission | 3 | 2019 | 294 | 0.520 |
Why?
| | A Kinase Anchor Proteins | 1 | 2017 | 72 | 0.520 |
Why?
| | Excitatory Amino Acid Agonists | 3 | 2014 | 41 | 0.510 |
Why?
| | Adenosine Triphosphate | 4 | 2013 | 489 | 0.490 |
Why?
| | Spine | 1 | 2017 | 179 | 0.480 |
Why?
| | Microscopy, Fluorescence | 3 | 2015 | 414 | 0.460 |
Why?
| | Second Messenger Systems | 1 | 2014 | 30 | 0.430 |
Why?
| | Models, Molecular | 8 | 2019 | 1587 | 0.430 |
Why?
| | Protein Conformation | 7 | 2021 | 936 | 0.410 |
Why?
| | Carrier Proteins | 6 | 2016 | 737 | 0.410 |
Why?
| | Membrane Proteins | 1 | 2019 | 1145 | 0.380 |
Why?
| | Protein Interaction Mapping | 2 | 2019 | 103 | 0.380 |
Why?
| | Actin Cytoskeleton | 3 | 2016 | 103 | 0.380 |
Why?
| | Mice, Inbred C57BL | 7 | 2024 | 5798 | 0.370 |
Why?
| | Protein Isoforms | 4 | 2018 | 395 | 0.360 |
Why?
| | Autophagy | 1 | 2014 | 285 | 0.350 |
Why?
| | Humans | 32 | 2025 | 138651 | 0.340 |
Why?
| | Nucleotides | 1 | 2011 | 127 | 0.330 |
Why?
| | Drug Design | 1 | 2011 | 165 | 0.330 |
Why?
| | Actins | 4 | 2016 | 419 | 0.330 |
Why?
| | Receptors, AMPA | 3 | 2024 | 140 | 0.330 |
Why?
| | Transfection | 5 | 2017 | 941 | 0.330 |
Why?
| | Nerve Tissue Proteins | 4 | 2019 | 600 | 0.320 |
Why?
| | Substrate Specificity | 4 | 2014 | 383 | 0.320 |
Why?
| | Protein Domains | 4 | 2019 | 288 | 0.320 |
Why?
| | Peptide Fragments | 4 | 2018 | 693 | 0.310 |
Why?
| | Gene Expression Regulation, Enzymologic | 4 | 2018 | 274 | 0.300 |
Why?
| | Cell Line | 8 | 2011 | 2876 | 0.300 |
Why?
| | Isoenzymes | 5 | 2014 | 303 | 0.300 |
Why?
| | Mice, Knockout | 3 | 2021 | 3028 | 0.290 |
Why?
| | Neuroprotection | 2 | 2020 | 43 | 0.280 |
Why?
| | Benzylamines | 5 | 2013 | 43 | 0.260 |
Why?
| | Cell Nucleus | 3 | 2012 | 607 | 0.250 |
Why?
| | Excitatory Postsynaptic Potentials | 2 | 2016 | 124 | 0.220 |
Why?
| | Enzyme Activation | 6 | 2017 | 810 | 0.220 |
Why?
| | Biological Products | 1 | 2007 | 231 | 0.220 |
Why?
| | Ionomycin | 2 | 2019 | 22 | 0.220 |
Why?
| | Protein Kinases | 1 | 2006 | 308 | 0.210 |
Why?
| | Binding Sites | 4 | 2014 | 1313 | 0.210 |
Why?
| | Signal Transduction | 7 | 2014 | 5086 | 0.210 |
Why?
| | D-Aspartic Acid | 1 | 2023 | 2 | 0.200 |
Why?
| | Sarcoplasmic Reticulum | 2 | 2003 | 43 | 0.200 |
Why?
| | Male | 16 | 2024 | 68260 | 0.200 |
Why?
| | Sulfonamides | 5 | 2013 | 505 | 0.190 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2023 | 69 | 0.190 |
Why?
| | Optogenetics | 1 | 2023 | 108 | 0.190 |
Why?
| | Cell Hypoxia | 2 | 2015 | 230 | 0.180 |
Why?
| | Nucleus Accumbens | 2 | 2013 | 148 | 0.180 |
Why?
| | Protein Subunits | 2 | 2013 | 229 | 0.180 |
Why?
| | Embryo, Mammalian | 2 | 2015 | 236 | 0.170 |
Why?
| | Single Molecule Imaging | 2 | 2021 | 36 | 0.170 |
Why?
| | Animals, Newborn | 3 | 2014 | 859 | 0.170 |
Why?
| | Swine | 1 | 2023 | 801 | 0.170 |
Why?
| | Neural Inhibition | 2 | 2012 | 177 | 0.160 |
Why?
| | Neurotoxins | 1 | 2020 | 29 | 0.160 |
Why?
| | Spodoptera | 3 | 2009 | 40 | 0.160 |
Why?
| | Enzyme Inhibitors | 6 | 2015 | 847 | 0.160 |
Why?
| | Point Mutation | 2 | 2014 | 236 | 0.160 |
Why?
| | Action Potentials | 2 | 2014 | 485 | 0.160 |
Why?
| | Recombinant Fusion Proteins | 3 | 2010 | 663 | 0.150 |
Why?
| | Protective Agents | 1 | 2019 | 42 | 0.150 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2006 | 873 | 0.150 |
Why?
| | Protein Structure, Tertiary | 2 | 2014 | 858 | 0.150 |
Why?
| | Nervous System | 1 | 1999 | 67 | 0.150 |
Why?
| | Purkinje Cells | 1 | 2019 | 68 | 0.150 |
Why?
| | Multigene Family | 1 | 2019 | 201 | 0.150 |
Why?
| | Mutation, Missense | 2 | 2014 | 334 | 0.150 |
Why?
| | Female | 8 | 2021 | 73763 | 0.150 |
Why?
| | RNA, Messenger | 3 | 2018 | 2815 | 0.140 |
Why?
| | Mutagenesis | 2 | 2011 | 182 | 0.140 |
Why?
| | Movement | 1 | 2020 | 281 | 0.140 |
Why?
| | Resuscitation | 1 | 2020 | 275 | 0.130 |
Why?
| | Kinetics | 2 | 2011 | 1645 | 0.130 |
Why?
| | Exons | 1 | 2018 | 353 | 0.130 |
Why?
| | Blotting, Western | 3 | 2009 | 1230 | 0.130 |
Why?
| | Membrane Potentials | 2 | 2014 | 283 | 0.130 |
Why?
| | Organ Culture Techniques | 1 | 2016 | 157 | 0.120 |
Why?
| | Mice, Mutant Strains | 1 | 2016 | 309 | 0.120 |
Why?
| | Proteins | 1 | 2001 | 1006 | 0.120 |
Why?
| | Dose-Response Relationship, Drug | 5 | 2013 | 2049 | 0.120 |
Why?
| | Miniature Postsynaptic Potentials | 1 | 2014 | 10 | 0.110 |
Why?
| | Ubiquitin-Specific Proteases | 1 | 2014 | 4 | 0.110 |
Why?
| | COS Cells | 2 | 2006 | 183 | 0.110 |
Why?
| | I-kappa B Kinase | 1 | 2014 | 54 | 0.110 |
Why?
| | Pepstatins | 1 | 2014 | 4 | 0.110 |
Why?
| | Electrical Synapses | 1 | 2014 | 11 | 0.110 |
Why?
| | Sequestosome-1 Protein | 1 | 2014 | 15 | 0.110 |
Why?
| | Phosphoserine | 1 | 2014 | 32 | 0.110 |
Why?
| | Serum Albumin, Bovine | 1 | 2014 | 66 | 0.110 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2014 | 48 | 0.110 |
Why?
| | Muramidase | 1 | 2014 | 79 | 0.110 |
Why?
| | RNA Interference | 2 | 2014 | 468 | 0.110 |
Why?
| | Pregnancy | 2 | 2018 | 6829 | 0.110 |
Why?
| | Staurosporine | 1 | 2013 | 19 | 0.100 |
Why?
| | RNA, Small Interfering | 2 | 2014 | 626 | 0.100 |
Why?
| | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2013 | 28 | 0.100 |
Why?
| | Gap Junctions | 1 | 2014 | 60 | 0.100 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2014 | 175 | 0.100 |
Why?
| | Genes, Reporter | 1 | 2014 | 274 | 0.100 |
Why?
| | Leucine | 1 | 2014 | 116 | 0.100 |
Why?
| | Protease Inhibitors | 1 | 2014 | 105 | 0.100 |
Why?
| | GTPase-Activating Proteins | 1 | 2013 | 82 | 0.100 |
Why?
| | Disease Models, Animal | 2 | 2021 | 4315 | 0.100 |
Why?
| | Heat-Shock Proteins | 1 | 2014 | 142 | 0.100 |
Why?
| | Ventral Tegmental Area | 1 | 2013 | 60 | 0.100 |
Why?
| | Statistics, Nonparametric | 1 | 2014 | 433 | 0.100 |
Why?
| | Myosin Type I | 1 | 2012 | 1 | 0.100 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2014 | 174 | 0.100 |
Why?
| | Cytoplasmic Vesicles | 1 | 2012 | 14 | 0.100 |
Why?
| | Microtubule-Associated Proteins | 1 | 2014 | 195 | 0.100 |
Why?
| | Glucose Transporter Type 4 | 1 | 2012 | 39 | 0.100 |
Why?
| | Amphetamine-Related Disorders | 1 | 2013 | 45 | 0.090 |
Why?
| | Cell Line, Transformed | 1 | 2012 | 145 | 0.090 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 2011 | 3 | 0.090 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 320 | 0.090 |
Why?
| | Base Sequence | 3 | 2002 | 2174 | 0.090 |
Why?
| | Cocaine | 1 | 2013 | 173 | 0.090 |
Why?
| | Cognition | 1 | 2019 | 1179 | 0.090 |
Why?
| | Solutions | 1 | 2011 | 168 | 0.090 |
Why?
| | Mice, Transgenic | 1 | 2016 | 2172 | 0.090 |
Why?
| | Serine | 1 | 2011 | 140 | 0.090 |
Why?
| | Alanine | 1 | 2011 | 152 | 0.080 |
Why?
| | Oxidation-Reduction | 1 | 2014 | 1076 | 0.080 |
Why?
| | Muscle, Skeletal | 2 | 2003 | 1729 | 0.080 |
Why?
| | Viral Fusion Proteins | 1 | 2010 | 19 | 0.080 |
Why?
| | Seizures | 1 | 2014 | 431 | 0.080 |
Why?
| | Gene Products, tat | 1 | 2010 | 22 | 0.080 |
Why?
| | PC12 Cells | 1 | 2010 | 40 | 0.080 |
Why?
| | Cell-Penetrating Peptides | 1 | 2010 | 22 | 0.080 |
Why?
| | Receptors, Adrenergic, alpha-1 | 1 | 2010 | 45 | 0.080 |
Why?
| | Conditioning, Classical | 1 | 2010 | 107 | 0.080 |
Why?
| | Electric Stimulation | 1 | 2010 | 276 | 0.080 |
Why?
| | Patch-Clamp Techniques | 1 | 2010 | 291 | 0.080 |
Why?
| | Insulin | 2 | 2012 | 2448 | 0.080 |
Why?
| | Immunohistochemistry | 5 | 2013 | 1731 | 0.070 |
Why?
| | Cell Membrane | 1 | 2012 | 716 | 0.070 |
Why?
| | Rats, Wistar | 2 | 2007 | 453 | 0.070 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1092 | 0.070 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 553 | 0.070 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2010 | 259 | 0.070 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2010 | 450 | 0.070 |
Why?
| | Behavior, Animal | 1 | 2010 | 512 | 0.060 |
Why?
| | Gene Expression | 2 | 2006 | 1488 | 0.060 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2006 | 4 | 0.060 |
Why?
| | Mutant Proteins | 1 | 2006 | 102 | 0.060 |
Why?
| | 2-Amino-5-phosphonovalerate | 1 | 2006 | 10 | 0.060 |
Why?
| | Subcellular Fractions | 1 | 2006 | 78 | 0.060 |
Why?
| | Trinucleotide Repeats | 1 | 2006 | 31 | 0.060 |
Why?
| | Chickens | 1 | 2006 | 189 | 0.060 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2006 | 104 | 0.060 |
Why?
| | Glycine | 1 | 2006 | 174 | 0.060 |
Why?
| | Models, Biological | 3 | 2003 | 1806 | 0.060 |
Why?
| | Amino Acid Substitution | 1 | 2006 | 309 | 0.060 |
Why?
| | Immunoblotting | 3 | 2013 | 309 | 0.060 |
Why?
| | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 2 | 2014 | 15 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 2003 | 44 | 0.050 |
Why?
| | Neurites | 1 | 2003 | 47 | 0.050 |
Why?
| | Integrins | 1 | 2003 | 95 | 0.050 |
Why?
| | Actinin | 1 | 2002 | 13 | 0.050 |
Why?
| | Immunoprecipitation | 2 | 2014 | 154 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2003 | 316 | 0.050 |
Why?
| | Stroke | 1 | 2010 | 1136 | 0.040 |
Why?
| | Islets of Langerhans | 1 | 2007 | 792 | 0.040 |
Why?
| | Cloning, Molecular | 1 | 2002 | 533 | 0.040 |
Why?
| | Kidney | 2 | 2006 | 1466 | 0.040 |
Why?
| | Cytoskeleton | 1 | 2001 | 194 | 0.040 |
Why?
| | Ganglia | 1 | 1999 | 18 | 0.040 |
Why?
| | Enzyme Induction | 1 | 1999 | 90 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2006 | 1746 | 0.040 |
Why?
| | Prostatic Neoplasms | 1 | 2007 | 1044 | 0.040 |
Why?
| | Microsomes | 1 | 1998 | 33 | 0.040 |
Why?
| | Cell Compartmentation | 1 | 1998 | 53 | 0.040 |
Why?
| | Organ Specificity | 1 | 1999 | 310 | 0.040 |
Why?
| | Enzymes, Immobilized | 1 | 1998 | 29 | 0.040 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2018 | 67 | 0.040 |
Why?
| | Head | 1 | 1999 | 115 | 0.030 |
Why?
| | Apoptosis | 1 | 2007 | 2546 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2019 | 250 | 0.030 |
Why?
| | Biological Transport | 1 | 1998 | 403 | 0.030 |
Why?
| | Microscopy, Immunoelectron | 1 | 2016 | 45 | 0.030 |
Why?
| | Microscopy, Electron | 1 | 2017 | 438 | 0.030 |
Why?
| | Spinal Cord | 1 | 1999 | 373 | 0.030 |
Why?
| | Pseudopodia | 1 | 2016 | 26 | 0.030 |
Why?
| | Protein Multimerization | 1 | 2017 | 193 | 0.030 |
Why?
| | Microscopy, Confocal | 2 | 2010 | 324 | 0.030 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2017 | 173 | 0.030 |
Why?
| | Sarcomeres | 1 | 1996 | 93 | 0.030 |
Why?
| | DNA, Complementary | 1 | 1996 | 274 | 0.030 |
Why?
| | DNA Primers | 1 | 1996 | 508 | 0.030 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2014 | 25 | 0.030 |
Why?
| | Polyubiquitin | 1 | 2014 | 6 | 0.030 |
Why?
| | Deubiquitinating Enzyme CYLD | 1 | 2014 | 3 | 0.030 |
Why?
| | Kainic Acid | 1 | 2014 | 34 | 0.030 |
Why?
| | Muscle Proteins | 1 | 1996 | 239 | 0.030 |
Why?
| | Ion Transport | 1 | 2014 | 60 | 0.030 |
Why?
| | Tissue Culture Techniques | 1 | 2014 | 82 | 0.030 |
Why?
| | Synaptic Membranes | 1 | 2013 | 16 | 0.030 |
Why?
| | Cell Fractionation | 2 | 2003 | 54 | 0.030 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2013 | 60 | 0.030 |
Why?
| | Polyribosomes | 1 | 2013 | 24 | 0.030 |
Why?
| | Conditioning, Operant | 1 | 2013 | 102 | 0.020 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2014 | 159 | 0.020 |
Why?
| | Amphetamine | 1 | 2013 | 37 | 0.020 |
Why?
| | Calcium Channels, L-Type | 1 | 2014 | 117 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 1996 | 1262 | 0.020 |
Why?
| | Rats, Long-Evans | 1 | 2013 | 122 | 0.020 |
Why?
| | Time Factors | 3 | 2013 | 6851 | 0.020 |
Why?
| | Potassium | 1 | 2013 | 147 | 0.020 |
Why?
| | Exocytosis | 1 | 2012 | 88 | 0.020 |
Why?
| | Dendrites | 1 | 2013 | 103 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2014 | 322 | 0.020 |
Why?
| | Cytosol | 1 | 2012 | 227 | 0.020 |
Why?
| | Neural Pathways | 1 | 2013 | 303 | 0.020 |
Why?
| | Calcium-Binding Proteins | 1 | 2013 | 215 | 0.020 |
Why?
| | Lysine | 1 | 2014 | 290 | 0.020 |
Why?
| | Drug Interactions | 1 | 2013 | 404 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2013 | 768 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 329 | 0.020 |
Why?
| | Endocytosis | 1 | 2012 | 175 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 1996 | 1233 | 0.020 |
Why?
| | Central Nervous System Stimulants | 1 | 2013 | 175 | 0.020 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2014 | 415 | 0.020 |
Why?
| | Up-Regulation | 1 | 2014 | 851 | 0.020 |
Why?
| | Liver | 1 | 1999 | 1805 | 0.020 |
Why?
| | Adrenergic alpha-1 Receptor Agonists | 1 | 2010 | 3 | 0.020 |
Why?
| | Phenylephrine | 1 | 2010 | 75 | 0.020 |
Why?
| | Calcineurin | 1 | 2010 | 107 | 0.020 |
Why?
| | Receptors, GABA-A | 1 | 2010 | 141 | 0.020 |
Why?
| | Thapsigargin | 1 | 2007 | 20 | 0.020 |
Why?
| | Androgen Receptor Antagonists | 1 | 2007 | 35 | 0.020 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 1 | 2007 | 49 | 0.020 |
Why?
| | Androstadienes | 1 | 2007 | 78 | 0.020 |
Why?
| | Luciferases | 1 | 2007 | 150 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2010 | 748 | 0.020 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2007 | 122 | 0.020 |
Why?
| | Prostate-Specific Antigen | 1 | 2007 | 165 | 0.020 |
Why?
| | Receptors, Androgen | 1 | 2007 | 150 | 0.010 |
Why?
| | Androgens | 1 | 2007 | 186 | 0.010 |
Why?
| | Doxorubicin | 1 | 2007 | 348 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2007 | 956 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2007 | 368 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 984 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2007 | 442 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2007 | 1032 | 0.010 |
Why?
| | Precipitin Tests | 1 | 2003 | 98 | 0.010 |
Why?
| | Isoquinolines | 1 | 2003 | 44 | 0.010 |
Why?
| | Organisms, Genetically Modified | 1 | 2003 | 15 | 0.010 |
Why?
| | Fibronectins | 1 | 2003 | 131 | 0.010 |
Why?
| | ras Proteins | 1 | 2003 | 148 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2010 | 2480 | 0.010 |
Why?
| | Luminescent Proteins | 1 | 2003 | 181 | 0.010 |
Why?
| | Immunosuppressive Agents | 1 | 2007 | 849 | 0.010 |
Why?
| | HeLa Cells | 1 | 2003 | 637 | 0.010 |
Why?
| | Cell Movement | 1 | 2003 | 969 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2003 | 892 | 0.010 |
Why?
|
|
Bayer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|